Outcomes of Simultaneous Kidney-Pancreas Transplantation With Positive Cross-Match

Transplantation Proceedings

Volumn 41, Issue 1, 2009, Pages 303-306

  Heilman, R L ^a   Chakkera, H ^a   Mazur, M ^a   Petrides, S ^a   Moss, A ^a   Mekeel, K ^a   Mulligan, D ^a   Reddy, K S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOINCOMPATIBILITY; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY PANCREAS TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; SURVIVAL RATE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTILYMPHOCYTE SERUM; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 60649121774     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.154     Document Type: Article

References (15)

1. Akalin E., Ames S., Sehgal V., et al. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients. Transplantation 76 (2003) 1444
2. Jordan S.C., Vo A., Bunnapradist S., et al. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 76 (2003) 631
3. Gloor J.M., DeGoey S.R., Pineda A.A., et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 3 (2003) 1017
4. Jordan S.C., Tyan D., Stablein D., et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 15 (2004) 3256
5. Stegall M.D., Gloor J., Winters J.L., et al. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 6 (2006) 346
6. Lefaucheur C., Nochy D., Hill G.S., et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 7 (2007) 832
7. Montgomery R.A., Zachary A.A., Racusen L.C., et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70 (2000) 887
8. Sis B., Campbell P.M., Mueller T., et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 7 (2007) 1743
9. Melcher M.L., Olson J.L., Baxter-Lowe L.A., et al. Antibody-mediated rejection of a pancreas allograft. Am J Transplant 6 (2006) 423
10. Carbajal R., Karam G., Renaudin K., et al. Specific humoral rejection of a pancreas allograft in a recipient of pancreas after kidney transplantation. Nephrol Dial Transplant 22 (2007) 942
11. Drachenberg C.B., Odorico J., Demetris A.J., et al. Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transplant 8 (2008) 1237
12. Drachenberg C.B., Papadimitriou J.C., Klassen D.K., et al. Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system. Transplantation 63 (1997) 1579
13. Gloor J.M., Sethi S., Stegall M.D., et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 3 (2007) 3
14. Nankivell B.J., Borrows R.J., Fung C.L., et al. The natural history of chronic allograft nephropathy. N Engl J Med 349 (2003) 2326
15. Lefaucheur C., Suberbielle-Boissel C., Hill G.S., et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 8 (2008) 324